Trial Profile
A Phase 2 Single-Arm Study of Gemcitabine in Combination with Oxaliplatin in Pediatric Patients with Relapsed or Refractory Neuroblastoma or Miscellaneous Solid Non-CNS Tumors
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 27 Jul 2020
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin
- Indications Neuroblastoma; Solid tumours
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 26 Jul 2020 This trial has been completed in United kingdom, according to European Clinical Trials Database record.
- 08 Jun 2011 New trial record